Diagnostic imaging system for skin cancer
This article was originally published in Start Up
MedLumics SL aims to capitalize on the growing market for non-melanoma skin cancer diagnosis with the first truly handheld device that uses light-based technology for diagnostic 3-D imaging. The start-up’s device comes in a mobile format and has a handheld imaging probe that contains three imaging modalities: optical coherence tomography, epiluminescent microscopy, and a miniaturized clinical camera.
You may also be interested in...
Tensions between industry and the European Commission on the issue of health claims for botanical food supplements were aired on the second day of the BAH's High Level Conference on the Future of Medicines, with the EC saying the EU Green Deal is now higher up on its list of priorities for the foreseeable future.
Issues over supply and the use of a skinny label have the potential to take a toll on the market for the fish oil drug icosapent ethyl, one analyst has claimed in the wake of Hikma’s recent generic launch.
The German Bundestag has adopted the Unified Patent Court’s draft ratification bill with the necessary qualified majority.